Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ·Healthcare·Biotechnology
$17.20
-0.32%
Mkt Cap $2.24B
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (10 analysts)
$16.00
Range $16.00 – $16.00
Implied Upside
-6.9%
Consensus $16.00 vs current $17.20
NASDAQ·Healthcare·Biotechnology
$17.20
-0.32%
Mkt Cap $2.24B
Buy
1
Hold
0
Sell
0
Price Target (10 analysts)
$16.00
Range $16.00 – $16.00
-6.9%
Consensus $16.00 vs current $17.20